FDA
-
-
-
-
-
-
-
Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
FDA lifts clinical hold on Tenaya's TN-201 gene therapy trial
-
-
-
-
-
-
-
Tenaya gets safety clearance to advance heart gene therapy trials
-
-
-
-
-
-
-
Tenaya Therapeutics (TNYA) Announces 2025 Strategic Priorities and Anticipated Milestones
-
-
-
-
-
-
-
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
-
-
-
-
-
-
-
Tenaya Therapeutics (TNYA) Announces FDA Clearance to Begin Clinical Testing of TN-401
-
-
-
-
-
-
-
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
322,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

